Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.

Kaleebu P, Kirungi W, Watera C, Asio J, Lyagoba F, Lutalo T, Kapaata AA, Nanyonga F, Parry CM, Magambo B, Nazziwa J, Nannyonjo M, Hughes P, Hladik W, Ruberantwari A, Namuwenge N, Musinguzi J, Downing R, Katongole-Mbidde E; HIV Drug Resistance Working group.

PLoS One. 2015 Dec 23;10(12):e0145536. doi: 10.1371/journal.pone.0145536. eCollection 2015.

2.

The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'.

Kaleebu P, Kamali A, Seeley J, Elliott AM, Katongole-Mbidde E.

Trop Med Int Health. 2015 Feb;20(2):E1-10. doi: 10.1111/tmi.12415. Epub 2014 Oct 29.

3.

Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection.

Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, Cannon DL, Khristova ML, Atimnedi P, Paddock CD, Crockett RJ, Flietstra TD, Warfield KL, Unfer R, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Rollin PE, Ksiazek TG, Nichol ST, Towner JS.

PLoS Pathog. 2012;8(10):e1002877. doi: 10.1371/journal.ppat.1002877. Epub 2012 Oct 4.

4.

MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.

Tornesello ML, Buonaguro L, Cristillo M, Biryahwaho B, Downing R, Hatzakis A, Alessi E, Cusini M, Ruocco V, Viviano E, Romano N, Katongole-Mbidde E, Buonaguro FM.

Biomarkers. 2011 Feb;16(1):42-50. doi: 10.3109/1354750X.2010.525664. Epub 2010 Oct 28.

PMID:
20979563
5.

Schistosomiasis among recreational users of Upper Nile River, Uganda, 2007.

Morgan OW, Brunette G, Kapella BK, McAuliffe I, Katongole-Mbidde E, Li W, Marano N, Okware S, Olsen SJ, Secor WE, Tappero JW, Wilkins PP, Montgomery SP.

Emerg Infect Dis. 2010 May;16(5):866-8. doi: 10.3201/eid1605.091740.

6.

Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era.

Tornesello ML, Biryahwaho B, Downing R, Hatzakis A, Alessi E, Cusini M, Ruocco V, Katongole-Mbidde E, Loquercio G, Buonaguro L, Buonaguro FM.

Virology. 2010 Mar 15;398(2):280-9. doi: 10.1016/j.virol.2009.12.005. Epub 2010 Jan 15.

7.

TP53 codon 72 polymorphism in classic, endemic and epidemic Kaposi's sarcoma in African and Caucasian patients.

Tornesello ML, Biryahwaho B, Downing R, Hatzakis A, Alessi E, Cusini M, Ruocco V, Katongole-Mbidde E, Buonaguro L, Buonaguro FM.

Oncology. 2009;77(5):328-34. doi: 10.1159/000260905. Epub 2009 Nov 23.

PMID:
19940524
8.

Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albarino CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE.

PLoS Pathog. 2009 Jul;5(7):e1000536. doi: 10.1371/journal.ppat.1000536. Epub 2009 Jul 31.

9.

Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC.

J Clin Oncol. 2009 Jul 20;27(21):3480-8. doi: 10.1200/JCO.2008.18.7641. Epub 2009 May 26.

10.

Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.

Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang ML, Drolette L, Selke S, Wald A, Corey L, Casper C.

PLoS One. 2009;4(1):e4222. doi: 10.1371/journal.pone.0004222. Epub 2009 Jan 20.

11.

Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda.

Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, Grosskurth H, Kaleebu P; Uganda HIV Drug Resistance Working Group.

AIDS Res Hum Retroviruses. 2008 Jun;24(6):889-95. doi: 10.1089/aid.2007.0317.

PMID:
18544019
12.

Intestinal parasites in Kaposi sarcoma patients in Uganda: indication of shared risk factors or etiologic association.

Lin CJ, Katongole-Mbidde E, Byekwaso T, Orem J, Rabkin CS, Mbulaiteye SM.

Am J Trop Med Hyg. 2008 Mar;78(3):409-12.

PMID:
18337336
13.

Gastrointestinal parasites in Ugandan cancer patients: a retrospective departmental review.

Robinson AJ, Katongole-Mbidde E.

Trop Doct. 2006 Jul;36(3):188-9.

PMID:
16884640
14.

Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.

Rochford R, Feuer G, Orem J, Banura C, Katongole-Mbidde E, Mwanda WO, Moormann A, Harrington WJ, Remick SC.

East Afr Med J. 2005 Sep;82(9 Suppl):S155-60. Review.

PMID:
16619692
15.

Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.

Mbulaiteye S, Marshall V, Bagni RK, Wang CD, Mbisa G, Bakaki PM, Owor AM, Ndugwa CM, Engels EA, Katongole-Mbidde E, Biggar RJ, Whitby D.

J Infect Dis. 2006 May 1;193(9):1250-7. Epub 2006 Mar 17.

PMID:
16586362
16.

Papillomavirus infection in the conjunctiva of individuals with and without AIDS: an autopsy series from Uganda.

Ateenyi-Agaba C, Weiderpass E, Tommasino M, Smet A, Arslan A, Dai M, Katongole-Mbidde E, Hainaut P, Snijders PJ, Franceschi S.

Cancer Lett. 2006 Jul 28;239(1):98-102. Epub 2005 Sep 6.

PMID:
16143449
17.

Capacity building for the clinical investigation of AIDS malignancy in East Africa.

Orem J, Otieno MW, Banura C, Katongole-Mbidde E, Johnson JL, Ayers L, Ghannoum M, Fu P, Feigal EG, Black J, Whalen C, Lederman M, Remick SC.

Cancer Detect Prev. 2005;29(2):133-45.

PMID:
15829373
18.

Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers.

Mbulaiteye SM, Biggar RJ, Pfeiffer RM, Bakaki PM, Gamache C, Owor AM, Katongole-Mbidde E, Ndugwa CM, Goedert JJ, Whitby D, Engels EA.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):474-9.

PMID:
15764964
19.

TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis.

Ateenyi-Agaba C, Dai M, Le Calvez F, Katongole-Mbidde E, Smet A, Tommasino M, Franceschi S, Hainaut P, Weiderpass E.

Mutagenesis. 2004 Sep;19(5):399-401.

PMID:
15388813
20.

Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda.

Mbulaiteye SM, Pfeiffer RM, Engels EA, Marshall V, Bakaki PM, Owor AM, Ndugwa CM, Katongole-Mbidde E, Goedert JJ, Biggar RJ, Whitby D.

J Infect Dis. 2004 Oct 15;190(8):1382-6. Epub 2004 Sep 10.

PMID:
15378429
21.

Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study.

Ateenyi-Agaba C, Weiderpass E, Smet A, Dong W, Dai M, Kahwa B, Wabinga H, Katongole-Mbidde E, Franceschi S, Tommasino M.

Br J Cancer. 2004 May 4;90(9):1777-9.

22.

Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda.

Mbulaiteye SM, Biggar RJ, Bakaki PM, Pfeiffer RM, Whitby D, Owor AM, Katongole-Mbidde E, Goedert JJ, Ndugwa CM, Engels EA.

J Natl Cancer Inst. 2003 Sep 3;95(17):1330-5.

PMID:
12953087
23.

Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.

Otieno MW, Banura C, Katongole-Mbidde E, Johnson JL, Ghannoum M, Dowlati A, Renne R, Arts E, Whalen C, Lederman MM, Remick SC.

J Natl Cancer Inst. 2002 May 15;94(10):718-32. Review.

PMID:
12011222
24.

First trial of the HIV-1 vaccine in Africa: Ugandan experience.

Mugerwa RD, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom DL, Byaruhanga R, Salata RA, Ellner JJ; HIV-1 Vaccine Trial Group.

BMJ. 2002 Jan 26;324(7331):226-9. Review. No abstract available.

25.

Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene.

Kakoola DN, Sheldon J, Byabazaire N, Bowden RJ, Katongole-Mbidde E, Schulz TF, Davison AJ.

J Gen Virol. 2001 Oct;82(Pt 10):2393-404.

PMID:
11562533
26.

The need for a vaccine against HIV/AIDS.

Katongole-Mbidde E.

J Int Assoc Physicians AIDS Care. 1997 Nov;3(11):26-9.

PMID:
11364810
27.

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R, Beral V.

AIDS. 1997 Nov;11(13):1619-26.

PMID:
9365767
28.

High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda.

Purvis SF, Katongole-Mbidde E, Johnson JL, Leonard DG, Byabazaire N, Luckey C, Schick HE, Wallis R, Elmets CA, Giam CZ.

J Infect Dis. 1997 Apr;175(4):947-50.

PMID:
9086156
29.

Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay.

Grant RM, Piwowar EM, Katongole-Mbidde E, Muzawalu W, Rugera S, Abima J, Stramer SL, Kataaha P, Jackson B.

Clin Diagn Lab Immunol. 1996 Nov;3(6):640-4.

30.

Diminished delayed hypersensitivity responses in the legs and feet of patients with endemic Kaposi's sarcoma.

Ziegler JL, Katongole-Mbidde E.

Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):173-4. No abstract available.

PMID:
8761581
31.
32.

Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma.

Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D.

J Infect Dis. 1996 Jan;173(1):248-51.

PMID:
8537669
33.

Absence of sex-hormone receptors in Kaposi's sarcoma.

Ziegler JL, Katongole-Mbidde E, Wabinga H, Dollbaum CM.

Lancet. 1995 Apr 8;345(8954):925. No abstract available.

PMID:
7535877
34.

beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans.

Piwowar EM, Tugume SB, Grant RM, Lutalo T, Pattishall K, Katongole-Mbidde E.

Clin Diagn Lab Immunol. 1995 Mar;2(2):236-7.

35.

Hematological reference ranges among healthy Ugandans.

Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW, Pattishall K, Katongole-Mbidde E.

Clin Diagn Lab Immunol. 1995 Mar;2(2):233-5.

36.

Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities.

Riley JP, Pestano GA, Hosford K, Francis C, Xie JM, Mugyenyi P, Kataaha P, Katongole-Mbidde E, Anokbonggo WW, Guyden J, et al.

Arch Virol. 1995;140(8):1393-404.

PMID:
7544970
37.

Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries.

Lurie P, Bishaw M, Chesney MA, Cooke M, Fernandes ME, Hearst N, Katongole-Mbidde E, Koetsawang S, Lindan CP, Mandel J, et al.

JAMA. 1994 Jan 26;271(4):295-301.

PMID:
8295289
38.

Preparations for AIDS vaccine trials. Respecting concerns of international host countries.

Katongole-Mbidde E.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S187-9. No abstract available.

PMID:
7865297
39.

Kaposi's sarcoma: recent developments.

Desmond-Hellmann SD, Katongole-Mbidde E.

AIDS. 1991;5 Suppl 1:S135-42. Review. No abstract available.

PMID:
1669910
40.

AIDS in Africa: problems for research and researchers.

Serwadda D, Katongole-Mbidde E.

Lancet. 1990 Apr 7;335(8693):842-3.

PMID:
1969569
41.

Diagnostic implications of genital Kaposi's sarcoma.

Katongole-Mbidde E, Banura C, Nakakeeto M.

East Afr Med J. 1989 Aug;66(8):499-502.

PMID:
2606033
42.

Central nervous system involvement in non-Hodgkin's lymphoma (excluding Burkitt's lymphoma) in Ugandan Africans.

Katongole-Mbidde E, Olweny CL, Mugerwa J, Owor R.

East Afr Med J. 1988 Dec;65(12):838-46. No abstract available.

PMID:
3234275
43.

Combination chemotherapy and surgery in the treatment of Wilm's tumour: preliminary communication.

Katongole-Mbidde E, Olweny CL, Otim D, Kiire CF, Carswell W, Owor R.

East Afr Med J. 1988 Oct;65(10):692-7. No abstract available.

PMID:
2852590
44.

Blackwater fever caused by Plasmodium vivax infection in the acquired immune deficiency syndrome.

Katongole-Mbidde E, Banura C, Kizito A.

Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):827. No abstract available.

45.

Duration of symptoms and histology of Hodgkin's disease.

Katongole-Mbidde E.

Lancet. 1984 Oct 6;2(8406):807-8. No abstract available.

PMID:
6148542
46.

Malignant lymphoma associated with rheumatoid arthritis.

Katongole-Mbidde E, Olweny CL, Kanyerezi BR, Owor R.

East Afr Med J. 1984 Jul;61(7):544-50. No abstract available.

PMID:
6400084
47.

Burkitt's lymphoma in the appendicular skeleton.

Fowles JV, Olweny CL, Katongole-Mbidde E, Lukanga-Ndawula A, Owor R.

J Bone Joint Surg Br. 1983 Aug;65(4):464-71.

PMID:
6874720
48.

Management of Kaposi's sarcoma.

Katongole-Mbidde E.

Lancet. 1982 Sep 4;2(8297):563. No abstract available.

PMID:
6125723
49.

Further experience in treating patients with hepatocellular carcinoma in Uganda.

Olweny CL, Katongole-Mbidde E, Bahendeka S, Otim D, Mugerwa J, Kyalwazi SK.

Cancer. 1980 Dec 15;46(12):2717-22.

PMID:
6160902
50.

Long-term experience with Burkitt's lymphoma in Uganda.

Olweny CL, Katongole-Mbidde E, Otim D, Lwanga SK, Magrath IT, Ziegler JL.

Int J Cancer. 1980 Sep 15;26(3):261-6.

PMID:
7287207

Supplemental Content

Loading ...
Support Center